XOLAIR Pages on BioPortfolio:

Biotechnology News XOLAIR Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/XOLAIR-news.htm...

BioPortfolio - Xolair
Xolair - BioPortfolio - Indepth. ... Companies working in the area of Xolair from Bioportfolio's Biocorporate database : BioPortfolio Logo. Company Name ...
http://www.bioportfolio.com/indepth/Xolair.html...

Biotechnology News Cerebrovascular Search
XOLAIR Safety Study Continues to 2012 Despite Increased Rate of O.. ... XOLAIR ( omalizumab) is an injected drug for asthma related. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

LeadDiscovery - PharmaNewsBytes European Respiratory Society
A 419-patient study showed that Xolair reduced the rate of clinically significant ... Xolair, the first biotechnology treatment for asthma, was
developed by ...
http://www.bioportfolio.com/LeadDiscovery/pharma_newsbytes_E...

Biotechnology News Food Safety Search
in an ongoing study of XOLAIR problems (http://www.xolairproblems.com). XOLAIR ( omalizumab) is an injected drug for asthma related. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio News: Biotracker - Profile of Tanox...
Valuation of the company is driven primarily by Xolair, as Tanox will receive approximately 10% royalties on worldwide Xolair sales. We expect Xolair to be
...
http://www.bioportfolio.com/news/Profile_of_Tanox.html...

BioPortfolio.com - BioWeb OMNITROPE SOMATROPIN RECOMBINANT isrupt ...
Home Contact Us Site Index Search [ Products -- Nutropin ] Products Home ONCOLOGY Avastin Herceptin Rituxan Tarceva IMMUNOLOGY Raptiva Xolair VASCULAR
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

...

IDEC-152 as a candidate treatment of asthma
Novel non-inhaled treatments such as Xolair stand to offer considerable benefit to asthmatics. Global revenue for 2001 from asthma therapies has been ...
http://www.bioportfolio.com/LeadDiscovery/PubMed-100302.html...

Results from other life science and pharmaceutical sites:

Genentech: Medicines: Xolair
Xolair is the first humanized therapeutic antibody for the treatment of asthma and the first approved therapy designed to target the antibody IgE, ...
http://www.gene.com/gene/products/information/immunological/...

Omalizumab - Wikipedia, the free encyclopedia
Omalizumab, trade-named Xolair, received approval by the U.S. Food and Drug ... Treatment with Xolair also reduces the number of FcεRI receptors on ...
http://en.wikipedia.org/wiki/Omalizumab...

Xolair® (omalizumab) for subcutaneous use – Genentech, Inc. Page 1 ...
Xolair (omalizumab) is indicated for adults and adolescents (12 years of age and above ... Prepare Xolair for subcutaneous injection using Sterile Water for ...
http://www.gene.com/gene/products/information/pdf/xolair-pre...

Early Communication about an Ongoing Safety Review of Omalizumab ...
16 Jul 2009 ... FDA is evaluating interim safety findings from an ongoing study of Xolair ( omalizumab) that suggests an increased number of cardiovascular ...
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInfo...

Xolair Medication Guide
right after receiving a Xolair injection or hours later. • after any Xolair injection. Anaphylaxis has occurred after the first Xolair injection or after
...
http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089829.pdf...

Genentech: Investors: Xolair - Historical Sales
Skip to Content for Xolair - Historical Sales Menu for Xolair - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors Menu ...
http://www.gene.com/gene/ir/financials/historical/xolair.htm...

Xolair (omalizumab injection) - Novartis Pharmaceuticals
Information on the Novartis prescription medicine Xolair.
http://www.pharma.us.novartis.com/products/name/xolair.jsp...

FDA Reviewing Preliminary Safety Information on Asthma Drug Xolair
16 Jul 2009 ... The US Food and Drug Administration announced today that it is conducting a safety review of Xolair (omalizumab), a drug used to treat ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/uc...

Novartis receives approval in EU for Xolair® to treat children age ...
24 Aug 2009 ... Landmark study shows Xolair reduces asthma attacks by 50 percent at one year[1] with a good overall safety and tolerability profile in ...
http://www.novartis.com/newsroom/media-releases/en/2009/1336...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.